URINARY N TELOPEPTIDE- THE IDEAL BIOMARKER FOR OSTEOPOROSIS.

Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006;17(12):1726-33.              

Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. The Lancet 1999;353(9156):878-82.                              

Pisani P, Renna MD, Conversano F, et al. Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques. World Journal of Radiology 2013;5(11):398-410.                     

Carlson-Newberry SJ, Costello RB. Emerging technologies for nutrition research: potential for assessing military performance capability. Institute of Medicine (US) Committee on Military Nutrition Research. Washington (DC): National Academies Press (US) 1997. ISBN-10: 0-309-05797-3.

Shetty S, Kapoor N, Bondu JD, et al. Bone turnover markers: emerging tool in the management of osteoporosis. Indian Journal of Endocrinology and Metabolism 2016;20(6):846-52.        

Hanson DA, Weis MA, Bollen AM, et al. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine. Journal of Bone and Mineral Research 1992;7(11):1251-8.             

Bonde M, Qvist P, Fledelius C, et al. Immunoassay for quantifying type 1 collagen degradation products in urine evaluated. Clinical Chemistry 1994;40(11 Pt 1):2022-5.    

Rabar S, Lau R, O’Flynn N, et al. Risk assessment of fragility fractures: summary of NICE guidance. BMJ 2012;345:e3698.           

Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis International 2001;12(5):417-27.           

Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. The Lancet 2002;359(9321):1929-36.                          

Gubala V, Harris LF, Ricco AJ, et al. Point of care diagnostics: status and future. Analytical Chemistry 2012;84(2):487-515.    

Liu L, Webster TJ. In situ sensor advancements for osteoporosis prevention, diagnosis and treatment. Current Osteoporosis Reports 2016;14(6):386-95.          

Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker Research 2017;5(1):18.                                   

Delmas PD, Eastell R, Garnero P, et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis International 2000;11(Suppl 6):S2-S17.     

Kleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocrine Practice 1996;2(1):13-9.              

Lombardi G, Lanteri P, Colombini A, et al. Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clinical Chemistry and Laboratory Medicine 2012;50(5):771-89.          

Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 2017;63(2):464-74.   

Fatayerji D, Eastell R. Age‐related changes in bone turnover in men. Journal of Bone and Mineral Research 1999;14(7):1203-10.    

Khosla S, Atkinson EJ, Melton LJ 3rd, et al. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. The Journal of Clinical Endocrinology & Metabolism 1997;82(5):1522-7.               

Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. The Journal of Clinical Endocrinology & Metabolism 1996;81(9):3366-71.                   

Bell NH, Hollis BW, Shary JR, et al. Diclofenac sodium inhibits bone resorption in postmenopausal women. The American Journal of Medicine 1994;96(4):349-53.            

Jones G, Nguyen T, Sambrook P, et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309(6956):691-5.              

Wishart JM, Need AG, Horowitz M, et al. Effect of age on bone density and bone turnover in men. Clinical Endocrinology 1995;42(2):141-6.